Company Filing History:
1 out of 3,539 
1 out of 1,996 
Years Active: 2010-2021
Title: Alison E Baird: Innovator in Stroke Research
Introduction
Alison E Baird is a prominent inventor based in Brooklyn, NY (US). She has made significant contributions to the field of medical research, particularly in the area of acute ischemic stroke. With a total of 2 patents, her work focuses on developing biomarkers and methods for diagnosing and treating this critical condition.
Latest Patents
Alison's latest patents include groundbreaking innovations such as "Biomarkers for predicting risk of acute ischemic stroke and methods of use thereof." This patent discloses biomarkers that are useful for the diagnosis and treatment of acute ischemic stroke. It also provides a quantitative assay method for accurately identifying transcript numbers in biological samples. Another significant patent is "Differential expression of molecules associated with acute stroke." This patent outlines methods for evaluating a stroke, determining whether a subject has had an ischemic stroke, assessing the severity or likely neurological recovery, and establishing treatment regimens. The methods include screening for expression in ischemic stroke-related genes and proteins, which are crucial for understanding the condition and improving patient outcomes.
Career Highlights
Throughout her career, Alison has worked with notable organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the State University of New York. Her work has been instrumental in advancing the understanding of acute ischemic stroke and developing effective diagnostic and treatment methods.
Collaborations
Alison has collaborated with esteemed colleagues such as David F Moore and Ehud Goldin. These partnerships have further enriched her research and contributed to the success of her innovative projects.
Conclusion
Alison E Baird is a remarkable inventor whose work in stroke research has the potential to save lives and improve patient care. Her patents reflect her dedication to advancing medical science and her commitment to finding solutions for acute ischemic stroke.